Announced
Completed
Synopsis
Adragos Pharma, a pharmaceutical contract development organization, completed the acquisition of Lamda Laboratories, an innovative contract development company that focus on providing quality research for Generic and Generic-plus developments, from Clinigen, a pharmaceutical services company focused on providing ethical access to medicines. Financial terms were not disclosed. "We are pleased to have carried out this acquisition. Lamda is of great importance to us because it extends our value chain coverage from pure Manufacturing to Development, allowing us to address a new customer group. At the same time, we can offer existing Lamda customers production capacity within the Adragos Group and existing Adragos Manufacturing customers a broader service offering," Andreas Raabe, Adragos Pharma CEO.
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.